New GLP-1 warnings will urge users to inform their doctors before surgery if they are taking the diabetes and weight loss drugs.
Awareness of Ozempic and Wegovy side effects may be driving more younger patients to report adverse events linked to the drugs, researchers speculate.
The FDA has received more than 200 reports of suicide or suicidal ideations linked to widely used diabetes and weight loss drugs like Ozempic, Wegovy, Mounjaro and Zepbound.
Health experts warn Ozempic and Wegovy use before surgery may increase the risk of vomiting, nausea and suffocation while under anesthesia.
Higher doses and longer durations of use both appeared to increase the gallbladder risks, researchers warn.
